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Before the severe acute respiratory syndrome (SARS)
outbreak, the Centers for Disease Control and Prevention’s
(CDC) legal authority to apprehend, detain, or conditionally
release persons was limited to seven listed diseases, not
including SARS, and could only be changed using a two-
step process: 1) executive order of the President of the
United States on recommendation by the Secretary, U.S.
Department of Health and Human Services (HHS), and 2)
amendment to CDC quarantine regulations (42 CFR Parts
70 and 71). In April 2003, in response to the SARS out-
break, the federal executive branch acted rapidly to add
SARS to the list of quarantinable communicable diseases.
At the same time, HHS amended the regulations to stream-
line the process of adding future emerging infectious dis-
eases. Since the emergence of SARS, CDC has increased
legal preparedness for future public health emergencies by
establishing a multistate teleconference program for public
health lawyers and a Web-based clearinghouse of legal
documents.
U
nder our American constitutional structure, the
“police power” (the authority of sovereign govern-
ments to enact laws and promote regulations that safeguard
the health, safety, and welfare of its citizens) is reserved to
the states by the 10th Amendment to the U.S. Constitution,
while the federal government exercises authority to regu-
late interstate and foreign commerce (1). As a result, state
and local health departments have primary responsibility
for controlling communicable diseases within their bound-
aries, while the federal government is primarily responsi-
ble for controlling transmission and spread of communica-
ble diseases from abroad and from one state to another.
Rapidly spreading epidemic diseases, such as severe acute
respiratory syndrome (SARS), have the potential to cross
interstate and international borders, potentially over-
whelming the ability of any one jurisdiction to respond,
despite the appropriate efforts taken by health officials.
Recognizing the cross border nature of some communica-
ble diseases and in light of this nation’s constitutional
structure, section 361 of the Public Health Service Act (42
United States Code section 264) authorizes the Health and
Human Services (HHS) Secretary to make and enforce
regulations necessary to prevent the introduction, trans-
mission, and spread of communicable diseases from for-
eign countries into the United States and from one state or
possession into another.
In enacting section 361, Congress recognized “the
impossibility of foreseeing what preventive measures may
become necessary” (2). Accordingly, Congress quite logi-
cally delegated to the executive branch the responsibility
of designating specific communicable diseases that would
be subject to federal isolation and quarantine measures. As
enacted in 1944, the statute required the President to list
the diseases for which quarantine was authorized through
executive order, on recommendation of the HHS secretary
and a group known as the National Advisory Health
Council (2). The first executive order listing “quaran-
tinable” diseases was issued by President Truman on
March 26, 1946 (3). Presidents Eisenhower, Kennedy, and
Reagan issued successive orders in 1954, 1962, and 1983,
respectively (4–6). The quarantinable diseases listed in
these executive orders were published in regulations found
in 21 Code of Federal Regulations (CFR) Part 1240 and 42
CFR Part 71. 
Historically, two sets of regulations promulgating sec-
tion 361 have existed: one designed to prevent the intro-
duction, transmission, and spread of communicable dis-
eases from foreign countries into the United States and the
other designed to prevent the interstate movement of com-
municable diseases within the United States. The Centers
for Disease Control and Prevention (CDC) had adminis-
tered the foreign quarantine regulations, while the U.S.
Food and Drug Administration (FDA) had administered
the interstate quarantine regulations. In addition to quaran-
tine, these regulations authorize a variety of other public
health measures, including reporting of ill passengers
onboard international conveyances, sanitary inspection of
arriving vessels and cargo, and restrictions on articles or
imports that may be sources of infection to human beings.
On August 16, 2000, FDA transferred a portion of its
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persons) to CDC, while retaining its authority to control
animals and other products that may transmit or spread
communicable diseases (7). The portion of FDA’s regula-
tions dealing with persons appearing in 21 CFR Part 1240
was transferred and recodified in CDC’s regulations at 42
CFR Part 70 (7). This transfer reduced potential delays in
implementing quarantine by consolidating authority to
quarantine persons with specified communicable diseases
under one federal agency.
As part of its planning for bioterrorism and especially
in light of the events of September 11, 2001, HHS sought
to further expedite quarantine procedures by reducing
potential delays involved in adding new diseases to the list
of quarantinable diseases. On June 12, 2002, President
Bush signed into law the Public Health Security and
Bioterrorism Preparedness and Response Act of 2002,
which, among other things, eliminated the need to convene
an advisory committee to amend the list of diseases (8).
The 2002 legislative changes also clarified that federal iso-
lation and quarantine measures apply not just to persons
who are infectious but also to persons who have been
exposed to a communicable disease and may potentially
become infectious (8).
HHS/CDC Legal Response
Before the outbreak of SARS, the list of federal quaran-
tinable diseases in the United States had not been revised
since 1983. It included cholera, diphtheria, infectious
tuberculosis, plague, smallpox, yellow fever, and viral
hemorrhagic fevers such as Marburg, Ebola, and Congo-
Crimean (4–6). Within days of the appearance of SARS,
other countries, including Canada, Hong Kong Special
Administrative Region, and Singapore instituted restrictive
health measures, including large-scale quarantine, to pre-
vent the further spread of the disease. In Ontario, Canada,
where SARS-associated coronavirus (SARS-CoV) was
transmitting in the population, the provincial government
made SARS a reportable, virulent, communicable disease
under Ontario’s Health Protection and Promotion Act. This
change enabled Ontario public health officers to issue
orders to enjoin infected persons from engaging in activi-
ties that may transmit SARS. At the federal level, Health
Canada also dispatched quarantine officers to internation-
al airports in Toronto and Vancouver, screened incoming
air passengers from infected areas for SARS, and distrib-
uted health alerts at major airports in Canada.
In the United States, the federal executive branch
moved rapidly to revise the list of quarantinable communi-
cable diseases by adding SARS to the diseases specified in
the April 4, 2003, executive order (9). This provided U.S.
federal health officials with quarantine powers comparable
to those in other countries affected by SARS. Similar to
actions taken in other countries, CDC quarantine officers
also began screening incoming passengers for symptoms
of SARS, distributing health alerts and advisories regard-
ing SARS, and coordinating with airport personnel in the
evaluation of sick passengers. Meanwhile, the nature of the
disease was rapidly evolving. For example, it was not
known whether the name of the disease might change from
SARS to something else as more was learned about the
disease. To deal with this possibility, the executive order
described SARS as follows: “a disease associated with
fever and signs and symptoms of pneumonia or other res-
piratory illness, is transmitted from person to person pre-
dominantly by the aerosolized or droplet route, and, if
spread in the population, would have severe public health
consequences” (9). HHS also streamlined the process of
adding new quarantinable diseases by eliminating the need
to dual-publish the list of diseases in an executive order
and in regulations (10). Future revisions to the list of quar-
antinable diseases require only an executive order, which
will be posted on the Web at: http://www.cdc.gov and
http://www.archives.gov/federal_register (10).
CDC has generally deferred to state and local health
authorities in the primary use of their own separate “police
power” quarantine authorities to restrict the movement of
persons within their boundaries. During the SARS out-
break, for example, some states relied on their own legal
authorities to control the movement of persons, so it was
not necessary for CDC to invoke federal quarantine power
to compel the isolation or quarantine of a person within a
state. On the basis of a long and successful history of col-
laboration with the states during public health emergen-
cies, CDC is likely to invoke federal quarantine power
only rarely, such as at ports of entry or other time-sensitive
situations. In these situations, and in others that are, for
example, inherently and necessarily beyond the capacity of
state and local jurisdictions to control, CDC has the legal
tools it needs to quarantine and isolate persons for SARS
and other specified communicable diseases.
Future Action
While this country was fortunate in that SARS did not
reach the scale of the outbreak in Toronto or Singapore, a
lesson learned from the outbreak is that federal, state, and
local officials will have to work closely in coordinating
quarantine actions at all levels of government. Historically,
public health legal counsels have served as “technicians”
in public health practice, asked by the public health agen-
cies they serve to interpret arcane statutory language and
render opinions. Legal preparedness, however, is increas-
ingly being viewed as a critical component of state and
local government public health preparedness activities. As
demonstrated repeatedly, in the SARS outbreak (quaran-
tine/isolation); in the introduction of monkeypox in the
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pet trade); and during West Nile virus season (mosquito
abatement/spraying programs), legal issues are nearly
always intertwined with public health responses. During
emergencies, communication among public health lawyers
at all levels (federal, state, and local) is a crucial part of the
“new normal” in public health. Until recently, however,
there was no ready means for public health lawyers to
communicate rapidly among themselves and quickly
access relevant legal information.
During the SARS outbreak, CDC established a series of
telephone conferences, whereby federal, state, and local
public health lawyers could discuss important legal issues
of the day and trade ideas about pending legal problems.
These teleconferences were particularly useful in exchang-
ing information concerning the interplay of quarantine
authority at the federal, state, and local levels and discus-
sion of procedural requirements involved in executing iso-
lation or quarantine orders. These legal teleconferences
were reinstituted and held daily during the peak of the
monkeypox outbreak. Additionally, during the monkeypox
outbreak, CDC developed a Web-based clearinghouse
where just-issued legal documents such as gubernatorial
executive orders and state and local health department
rules could be posted. CDC, through its Public Health Law
Program, plans to expand the scope of this clearinghouse
to reduce the time required to identify relevant legal docu-
ments and disseminate them to public health legal counsels
on a “real time” basis. The clearinghouse is available at:
http://www.phppo.cdc.gov/od/phlp/. The addition of a
Web-based clearinghouse and a teleconference capacity
increases CDC’s effectiveness in responding to public
health emergencies by more fully integrating lawyers into
the public health response.
Mr. Misrahi is an attorney with the Office of the General
Counsel of the U.S. Department of Health and Human Services,
Public Health Division, CDC/ATSDR Branch. Mr. Misrahi’s
principal clients include the CDC Office of Terrorism
Preparedness and Emergency Response and the CDC Division of
Global Migration and Quarantine. 
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